- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Thursday, 07 December 2000
-
Current Status:
Answered by Malcolm Chisholm on 19 January 2001
To ask the Scottish Executive what plans there are to introduce a central register of people diagnosed with autism.
Answer
There are plans to do so following the recommendations of the Learning Disability Review Report, for which I refer to question S1W-11328 answered on 30 November.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Jim Wallace on 19 January 2001
To ask the Scottish Executive (a) how many internal cases of (i) racial discrimination, (ii) racial harassment, (iii) sexual discrimination and (iv) sexual harassment in the police force were reported; (b) how many of these cases were investigated, and (c) how many of these cases resulted in prosecution in each year since 1995, broken down by police force
Answer
The detailed information requested is not held centrally.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Tuesday, 19 December 2000
-
Current Status:
Answered by Susan Deacon on 17 January 2001
To ask the Scottish Executive whether any employees of the Scottish Centre for Infection and Environmental Health have any declared interests in (a) SmithKline Beecham, (b) SmithKline and French and French Laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux and (e) Wellcome Foundation and whether it will detail what these interests are.
Answer
This information is not held centrally. I have however asked the Chief Executive of the Common Services Agency to look into this and to write to you.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Susan Deacon on 4 January 2001
To ask the Scottish Executive for what medical reason the licensing of single antigen measles and mumps vaccines is denied.
Answer
The vaccination policy in the UK for mumps, measles and rubella is to use the combined MMR vaccine. This policy is strongly supported by the recognised authorities on childhood immunisation, including the World Health Organisation. As a result no manufacturer is producing single antigen vaccine for measles or mumps with a European Medicines Evaluation Authority (EMEA) or a UK licence.
The use of single dose vaccines leaves children at risk of infection while they are waiting for the next single dose vaccine.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Malcolm Chisholm on 4 January 2001
To ask the Scottish Executive what steps it has taken to raise public awareness of the existence and symptoms of autism and Aspergers Syndrome and to improve performance in diagnosis and assessment.
Answer
The Learning Disability Review acknowledged the disparity across Scotland in assessing and diagnosing, and providing services to those with, autism.
The review report, published in May, provides a new lead. It recommends that the Scottish Society for Autism and the National Autistic Society co-ordinate the establishment of a national service network to improve awareness and understanding of the needs of people within the autistic spectrum disorder. The network will provide access to specialist knowledge and training in both health and other fields. The network will be supported by the new Scottish Centre for Learning Disabilities which is also being set up under the review. Work is progressing on these developments.
Autism is a priority area in the Executive's Special Educational Needs (SEN) Innovation Grants Programme. Grants totalling £504,000 have been awarded to six projects covering a range of objectives, including raising awareness and understanding of SEN in relation to autism issues.
In addition, we are funding from the Mental Health and Well Being Development Fund, an innovative Multi-Agency Service for Children with Autism in the Borders which could serve as a model for services throughout Scotland.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Malcolm Chisholm on 4 January 2001
To ask the Scottish Executive how many children in total and as a percentage of the total number of children have received the MMR vaccination in (a) this year and (b) each of the five previous years, broken down by health board.
Answer
The information requested has been provided by the Information and Statistics Division of the Common Service Agency of the NHS and is set out in the following tables:Primary Immunisation Uptake Rates of Mumps/ Measles and Rubella at 24 months; by Health Board; by year
1.
| Year ending |
| 31 December 1995 | 31 December 1996 | | 31 March 1997 |
| Number | Percentage | Number | Percentage | Number | Percentage |
Scotland | 58,612 | 94.1 | 55,634 | 94.6 | 55,781 | 94.4 |
Argyll and Clyde | 4,932 | 95.5 | 4,581 | 95.2 | 4,762 | 94.7 |
Ayrshire and Arran | 4,225 | 92.8 | 3,902 | 93.8 | 3,683 | 93.5 |
Borders | 1,030 | 91.2 | 1,094 | 95.9 | 1,084 | 95.0 |
Dumfries and Galloway | 1,618 | 92.4 | 1,566 | 94.5 | 1,554 | 94.2 |
Fife | 4,020 | 95.7 | 3,677 | 94.8 | 3,775 | 94.0 |
Forth Valley | 3,184 | 94.8 | 3,040 | 96.1 | 3,113 | 95.9 |
Grampian2 | 6,167 | 94.2 | 6,208 | 94.1 | 6,075 | 93.6 |
Greater Glasgow | 10,529 | 93.4 | 9,818 | 94.1 | 9,818 | 94.1 |
Highland | 2,276 | 89.8 | 2,191 | 91.2 | 2,191 | 91.2 |
Lanarkshire | 6,691 | 94.6 | 6,383 | 95.2 | 6,448 | 95.0 |
Lothian | 8,744 | 94.3 | 8,414 | 95.1 | 8,461 | 95.4 |
Orkney2 | 242 | 96.4 | 229 | 96.6 | 231 | 95.1 |
Shetland2 | 293 | 93.6 | 309 | 92.5 | 298 | 92.5 |
Tayside | 4,396 | 95.0 | 3,938 | 95.1 | 4,012 | 95.2 |
Western Isles | 265 | 96.0 | 284 | 91.6 | 276 | 94.2 |
| 31 March 1998 | 31 March 1999 | 31 March 2000 |
| Number | Percentage | Number | Percentage | Number | Percentage |
Scotland | 54,813 | 94.0 | 54,100 | 92.4 | 53,620 | 92.9 |
Argyll and Clyde | 4,652 | 93.9 | 4,498 | 91.7 | 4,502 | 92.6 |
Ayrshire and Arran | 3,851 | 93.3 | 3,803 | 91.9 | 3,760 | 93.7 |
Borders | 1,093 | 91.8 | 1,026 | 89.9 | 1,030 | 92.8 |
Dumfries and Galloway | 1,536 | 89.7 | 1,483 | 87.8 | 1,515 | 93.6 |
Fife | 3,615 | 95.0 | 3,599 | 92.8 | 3,592 | 92.5 |
Forth Valley | 2,927 | 95.4 | 3,050 | 94.2 | 3,049 | 94.6 |
Grampian2 | 5,688 | 94.3 | 5,587 | 92.8 | 5,630 | 92.3 |
Greater Glasgow | 9,792 | 93.2 | 9,474 | 92.8 | 9,356 | 93.8 |
Highland | 2,172 | 91.6 | 2,064 | 88.5 | 2,131 | 86.8 |
Lanarkshire | 6,287 | 94.7 | 6,288 | 91.8 | 6,193 | 92.9 |
Lothian | 8,387 | 95.0 | 8,429 | 93.8 | 8,186 | 93.5 |
Orkney2 | 219 | 94.0 | 215 | 95.6 | 203 | 98.1 |
Shetland2 | 272 | 90.4 | 256 | 91.4 | 254 | 91.7 |
Tayside | 4,030 | 95.9 | 4,074 | 93.4 | 3,991 | 93.4 |
Western Isles | 292 | 94.5 | 254 | 86.7 | 228 | 86.4 |
¹ 1995 and 1996 figures are based on calendar rather than financial years.
Source: Information and Statistics Division.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Susan Deacon on 3 January 2001
To ask the Scottish Executive which attenuated viruses are used in the creation of the MMR vaccine and for which diseases.
Answer
There are two MMR vaccines on the UK contract for childhood vaccines at the present time. The constituents of these vaccines are:
Aventis Pasteur MSD MMR -11 (PL 06745/0076)
Virus Measles live attenuated (Enders line of attenuated Edmonston strain)
Virus Mumps live attenuated (Jeryl Lynn B level strain)
Virus Rubella live attenuated (Wistar RA 27/3 strain)
SmithKline Beecham Priorix (PL 10592/0110)
Virus Measles live attenuated (Schwartz strain)
Virus Mumps live attenuated (RIT 4385 derived from Jeryl Lynn strain)
Virus Rubella live attenuated (Wistar RA 27/3 strain)
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Susan Deacon on 3 January 2001
To ask the Scottish Executive whether the current MMR vaccine used by the NHS is the same kind and type as that authorised for use in the USA and which manufacturers are used as suppliers of the vaccine, broken down by health board.
Answer
There are currently two brands of MMR vaccine available on the UK contract for childhood vaccines: PRIORIX (PL 10592/0110) manufactured by SmithKline Beecham and MMRII (PL 06745/0076) manufactured by Merck & Co UK and supplied by Aventis Pasteur MSD. Both brands have been supplied to the NHS in Scotland but it is not possible to provide a breakdown by health board.
The Medicines Control Agency has advised that of these two vaccines, MMRII (PL 10592/0110) is identical to that supplied by the manufacturer Merck to the USA market. As far as they can ascertain, Priorix is not authorised for use in the USA at the present time.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Wednesday, 13 December 2000
-
Current Status:
Answered by Susan Deacon on 3 January 2001
To ask the Scottish Executive what the current cost is per child of the MMR vaccine.
Answer
The total cost per child including staff time and materials is not quantified. The NHS List Price of the vaccine ranges from £4.45 per dose to £5.21 per dose depending on the manufacturer. The NHS receives a discount on this price depending on volume.
- Asked by: Mr Lloyd Quinan, MSP for West of Scotland, Scottish National Party
-
Date lodged: Thursday, 07 December 2000
-
Current Status:
Answered by Nicol Stephen on 21 December 2000
To ask the Scottish Executive how many special educational needs units within state schools have closed from 1997 to 2000.
Answer
This information is not held centrally.